Clinical Trials
32 trialsTislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
Shandong Public Health Clinical Center
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Henan Cancer Hospital
Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
The First People's Hospital of Lianyungang
FTANLCNDG
Qianfoshan Hospital
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
Jiangsu Simcere Pharmaceutical Co., Ltd.
RELIEF
Shanghai Chest Hospital
SBRTLCES
Peking University Third Hospital
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC
Peking University Cancer Hospital & Institute
Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC
Third Military Medical University
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Endostar First-line Treatment of Advanced NSCLC
China Medical University, China
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Xinqiao Hospital of Chongqing
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
Anhui Provincial Hospital
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC
Tianjin Medical University Cancer Institute and Hospital
Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)
Hunan Province Tumor Hospital
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.
Peking University Third Hospital
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Zhejiang University
Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in Phaseâ… B
Xinjiang Medical University
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
Jiangsu Simcere Pharmaceutical Co., Ltd.
DP-EN-RT
Sun Yat-sen University
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)
Fudan University
Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Xijing Hospital
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
Dengshan
Shanghai Jiao Tong University School of Medicine
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer
Chinese Academy of Sciences
NSCLC
Simcere Pharmaceutical Co., Ltd